Clinical Trial

Study on Early Genetic Screening and Precise Strategy of Neonatal Critical Illness

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 20, 2025 (before its estimated November 2025 completion). Its status may not reflect the trial's current state.
Summary
The researchers hope to establish an overall program of early genetic screening for neonatal critical illness in China, and to develop precise intervention strategies to assist clinical diagnosis and treatment of hereditary critical illness.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2021-05-25; most recent amendment 2025-02-19.
Trial Details
NCT Number NCT04905537
Lead Sponsor Children's Hospital of Fudan University
Collaborators: International Peace Maternity and Child Health Hospital, Obstetrics & Gynecology Hospital of Fudan University, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Children's Medical Center, Shanghai Children's Hospital
Conditions Genetic Screening, Hereditary Disease, Newborn, Stillbirth
Enrollment 4,000 participants
Start Date 2021-01-01
Primary Completion 2025-11 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2025-02-20